Friday, September 11, 2020 5:24:18 PM
144 patients is only 72 patients actually getting the drug which is a very small number. Until they get the manufacturing setup they might as well complete the trial.
The manufacturing of the drug will also need approval and at times can be a major problem. See MNTA a few years back.
Has there been a formal press release on the company that is doing the manufacturing of IV drug supply?
Do we know for sure the inhaler trial has started in the EU?
The manufacturing of the drug will also need approval and at times can be a major problem. See MNTA a few years back.
Has there been a formal press release on the company that is doing the manufacturing of IV drug supply?
Do we know for sure the inhaler trial has started in the EU?
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
